Table 2. First-line chemotherapy.
Schedule | 5FU administration | No. of patients |
---|---|---|
Bolus FUFOL | Bolus | 22 |
LV5FU2 | Bolus+infusional | 31 |
5FU continuous infusion | Infusional | 49 |
FOLFOX2 | Infusional | 25 |
FOLFOX4 | Bolus+infusional | 61 |
FOLFOX6 | Bolus+infusional | 78 |
FOLFIRI | Bolus+infusional | 41 |
Chronomodulated FF | Infusional | 110 |
Chronomodulated FFL | Infusional | 186 |
Various bolus | Bolus | 18 |
Various infusional | Infusional | 10 |
LV5FU2: folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
FOLFOX2: oxaliplatin 100 mg sqm−1 d1; folinic acid 300 mg sqm day−1 in 2 h infusion; 5FU 1500–1800 mg sqm day−1 in 22 h infusion d1-2q14d
FOLFOX4: oxaliplatin 85 mg sqm−1 d1; folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
FOLFOX6: oxaliplatin 100 mg sqm d1; folinic acid 200 mg sqm−1 2 h infusion; 5FU 400 mg sqm−1 bolus; 5FU 2400–3000 mg sqm−1 46 h infusion
FOLFIRI: irinotecan 180 mg sqm−1 d1; folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
Chronomodulated FF: folinic acid 300 mg sqm day−1; 5FU 700–1000 mg sqm day−1 d1-4q14d
Chronomodulated FFL: oxaliplatin 25 mg sqm day−1; folinic acid 300 mg sqm day−1; 5FU 700–1000 mg sqm day−1 d1-4q14d.